Frontiers in Immunology (May 2024)
Editorial: Community series in the immune escape mechanism and novel immunotherapeutic strategies of leukemia, volume II
- Yixiang Han,
- Qianping Li,
- Qianping Li,
- Qianping Li,
- Yicheng Tan,
- Yicheng Tan,
- Yicheng Tan,
- Kang Yu,
- Kang Yu,
- Kang Yu,
- Shenghui Zhang,
- Shenghui Zhang,
- Shenghui Zhang,
- Shenghui Zhang
Affiliations
- Yixiang Han
- Central Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
- Qianping Li
- Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
- Qianping Li
- Institute of Hematology, Wenzhou Medical University, Wenzhou, Zhejiang, China
- Qianping Li
- Wenzhou Key Laboratory of Hematology, Wenzhou, Zhejiang, China
- Yicheng Tan
- Institute of Hematology, Wenzhou Medical University, Wenzhou, Zhejiang, China
- Yicheng Tan
- Wenzhou Key Laboratory of Hematology, Wenzhou, Zhejiang, China
- Yicheng Tan
- Laboratory Animal Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
- Kang Yu
- Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
- Kang Yu
- Institute of Hematology, Wenzhou Medical University, Wenzhou, Zhejiang, China
- Kang Yu
- Wenzhou Key Laboratory of Hematology, Wenzhou, Zhejiang, China
- Shenghui Zhang
- Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
- Shenghui Zhang
- Institute of Hematology, Wenzhou Medical University, Wenzhou, Zhejiang, China
- Shenghui Zhang
- Wenzhou Key Laboratory of Hematology, Wenzhou, Zhejiang, China
- Shenghui Zhang
- Laboratory Animal Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
- DOI
- https://doi.org/10.3389/fimmu.2024.1426570
- Journal volume & issue
-
Vol. 15
Abstract
No abstracts available.Keywords
- leukemia
- immune escape
- immunotherapeutic strategies
- chimeric antigen receptor T-cell therapy
- cytokine-release syndrome
